SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001610618-18-000087
Filing Date
2018-08-09
Accepted
2018-08-08 18:01:26
Documents
3
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A q110-qa2018x03.htm 10-Q/A 34845
2 CERTIFICATION OF CEO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934 q12018exhibit311.htm EX-31.1 11649
3 CERTIFICATION OF CFO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934 q12018exhibit312.htm EX-31.2 11640
  Complete submission text file 0001610618-18-000087.txt   59284
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-36912 | Film No.: 181002685
SIC: 2836 Biological Products, (No Diagnostic Substances)